Engineered Surfaces for Multiplexed DNA and RNA Modification Profiling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for profiling epitranscriptomic and epigenetic modifications in nucleic acids lack sensitivity, specificity, and are not amenable to multiplexed detection, leading to inconsistent and low-resolution identification of modifications, which hinders understanding of their role in health and disease.

Innovation Solution

Compositions and methods utilizing engineered surfaces with binding domains and adapters that specifically recognize non-canonical features of nucleic acids, enabling high-throughput, sensitive, and accurate profiling of multiple modifications by transferring nucleic acid barcodes for sequencing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If chemical derivatization methods and molecular recognition using antibodies are used for profiling DNA and RNA modifications, then profiling capability is provided, but sensitivity is low and nucleic acid degradation/fragmentation occurs

Engineering Contradiction:
Improvemodification identification accuracyVSAvoidnucleic acid integrity
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent introduces engineered surface-bound binding domains as intermediary molecules that capture nucleic acid modifications without requiring chemical derivatization. These binding domains are immobilized on surfaces and serve as mediators between the modification targets and detection systems, enabling direct recognition and enrichment while preserving nucleic acid integrity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces chemical derivatization methods with engineered protein-DNA/RNA recognition systems. Instead of using chemical reactions to tag modifications, the invention uses specifically engineered binding domains that naturally recognize and bind to modified nucleic acids, substituting chemical mechanisms with biological recognition mechanisms.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If existing sequencing methods are used for detecting epitranscriptomic modifications, then detection capability is provided, but sensitivity is low and location resolution is poor

Engineering Contradiction:
Improvemodification location resolutionVSAvoiddetection sensitivity
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent segments the detection process into distinct functional modules: surface-immobilized binding domains for capture, adapter molecules for bridging, and barcode sequences for identification. This segmentation allows each component to be optimized for its specific function, achieving both high sensitivity and precise location resolution simultaneously.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent adds the dimension of spatial organization by immobilizing binding domains on surfaces, creating a two-dimensional array of capture sites. This surface-based approach enables parallel processing of multiple nucleic acid molecules while maintaining individual molecule integrity, thereby improving both sensitivity and location resolution.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Adaptability or versatility

If conventional methods are used for analyzing DNA and RNA modifications, then analysis capability is provided, but multiplexed detection is not amenable

Engineering Contradiction:
Improvemultiplexed detection capabilityVSAvoidmethod complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent creates universal surface-bound binding domains that can be designed to recognize different nucleic acid modifications through engineered specificity. The same platform architecture can be applied to detect various modifications by simply changing the binding domain sequence, enabling multiplexed detection without increasing overall method complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent uses parameter changes in the binding domain sequences to achieve different specificities for various modifications. By modifying amino acid sequences while maintaining the overall structural framework, the system can detect multiple types of modifications using the same experimental platform, simplifying multiplexed analysis.

Inventive Principle:
Principle #35Parameter changes

4Productivity

If chemical derivatization and antibody-based methods are used, then modification profiling is enabled, but high-throughput capability is limited

Engineering Contradiction:
Improveprofiling throughputVSAvoidmodification identification accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent transitions from solution-phase chemistry to surface-based analysis, utilizing two-dimensional surface arrays to enable parallel processing of numerous nucleic acid molecules simultaneously. This surface immobilization approach dramatically increases throughput while maintaining identification accuracy through the specificity of engineered binding domains.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent merges multiple functions into a single surface-immobilized binding domain construct: capture of modified nucleic acids, enrichment of targets, and preparation for sequencing. This consolidation eliminates multiple separate steps required by conventional methods, thereby increasing throughput without compromising precision.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enable simultaneous, high-resolution identification and localization of DNA and RNA modifications, allowing for the determination of their nature, location, and abundance, thereby facilitating the discovery of key regulatory mechanisms in biology and disease.

Implementation Method 1

molecular recognition (typically using antibodies, both for enrichment and detection)

Methodology Applied
Scientific EffectMolecular recognition:

Data Source

PatentUS20250263794A1RNA and DNA analysis using engineered surfaces
Publication Date: 2025.08.21 ALIDA BIOSCIENCES INC
  • US20250263794A1 patent drawing
  • US20250263794A1 patent drawing
  • US20250263794A1 patent drawing

AI summary

Provided herein are compositions and methods for the multiplexed profiling of RNA and DNA modifications across transcriptomes and genomes, respectively. The methods combine molecular recognition of non-canonical features (e.g., base modifications, backbone modifications, lesions, and/or structural elements) of a target nucleic acid with a step of writing the information from this recognition event into the neighboring genetic sequence of the target nucleic acid using a barcode. The resultant barcoded nucleic acids are then converted into sequencing libraries and read by DNA/RNA sequencing methods. This step reveals the sequence of the barcode, which is correlated with the non-canonical feature in the target nucleic acid(s). The high throughput profiling methods described herein allow for identification and/or localization of one or more modifications in a target nucleic acid. The methods also allow for identification of the nature and location of several or all DNA/RNA modifications in parallel.